Innovative solutions
    for more effective diagnostics

Presentation

Products

Pathogens

Client Care

Science

IFU

Contact

Blog

NEWS

 

Products Range

NEW-Resist Range

Oxa-48

KPC

RESIST-3 O.O.K.

RESIST-3 O.K.N.

Immunochromatographic Range

Pathogens detection

40/41 Adenovirus

Adenovirus

Clostridium difficile

Cryptosporidium & Giardia

Cryptosporidium

Escherichia coli O157

Rotavirus & 40/41 Adenovirus

Giardia

Helicobacter pylori

Influenza A & B viruses

Legionella

Respiratory Adenovirus

Rotavirus & Adenovirus

Rotavirus

Respiratory Syncytial Virus (RSV)

Streptococcus (group A)

Trypanosoma brucei gambiense (HAT)

Quatro-VeT (Veterinary)

Molecular Range

Leishmania

Pseudomonas aeruginosa

Scientific partners

PARADIS (Biowin)

CCH Fever (EC-FP7)

Chips 4 life (EC-FP7)

Nidiag (EC-FP7)

AquaVir (FP7)

Nareb (FP7)

Euroleish (H2020-MSCA-ITN)

ebolaMoDRAD (IMI-2)

 

Products  >  Human-Field  >  Influenza A and B viruses  >  Science

INFLUENZA A & B - Science

 

• Preliminary study - Verification of sensitivity of the Influ A respi - strip kit with new pandemic virus "pandemic H1N1 2009".

Sensitivity of InfluA RespiStrip

 

• Recognition of H1N1 field strains by the Influ-A&B Respi-Strip kit, season 2007-2008

Recognition of H1N1 by InfluAB RespiStrip

Traduction française

Detection de InfluAB

 

• Evaluation of the Influ-A&B Respi-Strip test (Coris BioConcept) at the Department of Virology, University of Turku, Finland.

Vainionpää R

December 2006.

Evaluation of InfluAB RespiStrip Turku

 

• Flu testings: ICT versus PCR, 2010

Flu testings ICT versus PCR

 

• Evaluation of InfluA&B Respi-Strip for the rapid detection of influenza A and B viruses in respiratory samples

Degallaix S, Defoor M, Denorme L, Lefèvre O, Labrune V, Laurent T, Reynders M, Leclipteux T, Mertens P

17th ECCMID, Munich 31 March-3 April 2007

Evaluation of InfluAB RespiStrip

 

• Near-patient assays for diagnosis of influenza virus infection in adult patients.

Steininger C, Redlberger M, Graninger W, Kundi M, Popow-Kraupp T

Clin Microbiol Infect. 2009 Mar;15(3):267-73. Epub 2009 Jan 29.

Abstract

Rapid and reliable diagnosis of influenza is essential for identification of contagious patients and effective patient management. Near-patient assays allow establishment of the diagnosis within minutes in young children, and this study aimed to evaluate near-patient assays in relation to the patient's age. A total of 194 patients with laboratory-confirmed influenza A/H3N2 virus infection, diagnosed within a prospective cohort study, were included. Cryopreserved nasopharyngeal swabs collected from these patients were tested by four near-patient assays (Binax Now Influenza A&B, Quick S-Influ A/B, Influ-A&B Respi-Strip, and Actim Influenza A&B). The main outcome measure was sensitivity of the near-patient assays in relation to the age of patients. The Binax Now, Quick S-Influ, Influ-A&B Respi-Strip and Actim assays had overall sensitivities of 19%, 18%, 26%, and 40%, respectively. The estimated sensitivity for influenza A/H3N2 virus detection in nasopharyngeal swabs was 17-56% in children 1 year of age and decreased to 8-22% in patients 80 years of age (logistic regression). The sensitivity of the Influ-A&B Respi-Strip and Actim assays decreased significantly with increasing age (p 0.014 and p 0.033, respectively (logistic regression)), a trend for decrease was observed for the Binax Now assay (p 0.074 (logistic regression)), and the low sensitivity of the Quick S-Influ assay was similar in children and adults. Less than one-fourth of diagnosed influenza A/H3N2 virus infections can be identified in elderly patients using a near-patient assay. Consequently, near-patient assays are of limited value for confirming the diagnosis when influenza is clinically suspected in adults. Antiviral therapy and additional diagnostic procedures cannot be withheld on the basis of a negative near-patient assay result, particularly in adult patients.

 

 

More information:

http://www.who.int/csr/disease/influenza/influenzanetwork/en/

http://www.cdc.gov/flu/

http://www.euroflu.org/index.php

 

 

Home   -   Site Map   -   Privacy Policy   -   Contact   -   FAQ                   All rights reserved CorisBioconcept SPRL 1996-2012©                           www.corisbio.com

Web traffic Optimisation
Universem

Design, Programming & hosting
Impact communication